Anti c-Met antibodies

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9884917
SERIAL NO

14098849

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to antibodies that specifically bind to the human c-Met receptor protein and that act as strict antagonists of hepatocyte growth factor (HGF)-mediated activation of the c-Met receptor and also inhibit HGF-independent activation of the human c-Met protein.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ARGEN-X N.V.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Basilico, Cristina Pavarolo, IT 10 56
De, Haard Johannes Oudelande, BE 18 83
De, Jonge Natalie Aalst, BE 14 48
Dreier, Torsten Sint-Martens-Latem, BE 46 497
Festjens, Els Zwevegem, BE 7 61
Hultberg, Anna Sint-Martens-Latem, BE 9 96
Michieli, Paolo Rivalta di Torino, IT 18 66
Saunders, Michael Brussels, BE 52 1168

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 6, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 6, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00